ITEMS IN AFP WITH KEYWORD:
Coronary Artery Disease/Coronary Heart Disease
Oct 01, 2021 Issue
Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors [Putting Prevention into Practice]
A 36-year-old patient, L.B., with a history of hypertension presents for a wellness visit. The patient's mother had a stroke at 65 years of age and the patient's older brother recently had a heart attack. L.B. has an estimated 10-year cardiovascular risk of 6%, and L.B.'s body mass index is 29 kg per m2.
The use of race in clinical decision-making is a source of controversy in U.S. modern medicine. Definitions of race are inconsistent throughout the medical literature and in medical education, and most experts in biology and social sciences agree that race has a limited biologic basis and is actuall...
Egg consumption is not associated with the occurrence of cardiovascular events over an average of 12 years.
Does lipid lowering reduce major vascular events in patients 75 years and older?
Colchicine, 0.5 mg daily, significantly reduces the risk of myocardial infarction and ischemia-driven revascularization.
Mar 15, 2021 Issue
Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults with Cardiovascular Risk Factors: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends offering or referring adults with cardiovascular disease (CVD) risk factors to behavioral counseling interventions to promote a healthy diet and physical activity.
For patients with left main disease, PCI with a drug-eluting stent and CABG had similar all-cause mortality rates at 10 years. For those with three-vessel disease, CABG is associated with lower 10-year mortality.
This study found a significant reduction in mortality and morbidity among patients who took their once-daily anti-hypertensive medications at bedtime instead of in the morning. No significant difference occurred in compliance rates between bedtime and morning ingestion times. Individual experiences may differ in clinical practice.
Jan 1, 2020 Issue
PLAC Test for Lp-PLA2 Activity to Predict Coronary Heart Disease [Diagnostic Tests: What Physicians Need to Know]
The PLAC test is a blood test used to measure serum activity of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme that breaks down oxidized low-density lipoprotein in the vascular wall.
Although coronary artery calcium testing may slightly improve future risk prediction, this theoretical benefit is outweighed by its potential harms.